首页> 外文期刊>International Journal of Research in Medical Sciences >Prophylactic use of Midazolam, Ketamine, and Ketamine plus Midazolam for prevention of perioperative shivering during spinal anaesthesia in patients undergoing infraumbilical surgeries: a comparative study
【24h】

Prophylactic use of Midazolam, Ketamine, and Ketamine plus Midazolam for prevention of perioperative shivering during spinal anaesthesia in patients undergoing infraumbilical surgeries: a comparative study

机译:咪达唑仑,氯胺酮和氯胺酮加咪达唑仑的预防性使用,以防止脐带下手术患者在脊髓麻醉期间围手术期发抖:一项比较研究

获取原文
           

摘要

Background: Shivering is a common problem faced by an anaesthesiologist during perioperative period. Shivering occurs during both general anaesthesia and regional anaesthesia but it is more troublesome during neuraxial anaesthesia. To evaluate the effectiveness of intravenous Midazolam, Ketamine and combination of Midazolam with Ketamine in control of shivering. Methods: The study was conducted in 90 ASA I and II patients receiving neuraxial anaesthesia with comparable dose of hyperbaric bupivacaine. The patients were allocated in three groups of 30 each to receive Midazolam 75 mcg/kg, ketamine 0.5 mg/kg and Midazolam 37.5 mcg/kg plus Ketamine 0.25 mg/kg IV after the appearance of shivering. Disappearance and recurrence of shivering as well as temperature and haemodynamics were recorded with scheduled intervals. Results: IV Midazolam plus Ketamine at the dose of 37.5 mcg/kg and 0.25 mg/kg is more effective in prophylaxis of shivering than IV Midazolam 75 mcg/kg or IV Ketamine 0.5 mg/kg. Small number of patients showed, clinically as well as statistically insignificant, incidence of hypotension, bradycardia and respiratory depression of various degrees at various time intervals. Conclusions: Thus, IV Midazolam plus Ketamine at the dose of 37.5 mcg/kg and 0.25 mg/kg IV is more effective in prophylaxis of shivering than IV Midazolam 75 mcg/kg or IV Ketamine 0.5 mg/kg following subarachnoid blockade for infra umbilical surgery. The side effects like Hypotension, nausea, vomiting and pruritus are also very less with combination and prove that it is a better agent for prophylaxis of shivering following regional anesthesia.
机译:背景:发抖是麻醉师在围手术期面临的常见问题。在全身麻醉和区域麻醉期间都会发抖,但在神经麻醉时会更加发抖。评估静脉注射咪达唑仑,氯胺酮以及咪达唑仑和氯胺酮的组合在控制发抖方面的有效性。方法:该研究在90名接受神经麻麻的ASA I和II患者中进行,并接受了相同剂量的高压布比卡因。将患者分为三组,每组30只,在出现瑟瑟发抖后接受咪达唑仑75 mcg / kg,氯胺酮0.5 mg / kg和咪达唑仑37.5 mcg / kg加上氯胺酮0.25 mg / kg IV。以预定的时间间隔记录颤抖的消失和复发以及温度和血液动力学。结果:IV咪达唑仑加氯胺酮的剂量分别为37.5 mcg / kg和0.25 mg / kg,比IV咪达唑仑75 mcg / kg或IV氯胺酮0.5更好。在临床上和统计学上无关紧要的是,少数患者在不同的时间间隔出现了不同程度的低血压,心动过缓和呼吸抑制的发生率。结论:因此,静脉内咪达唑仑加氯胺酮的剂量分别为37.5 mcg / kg和0.25 mg / kg静脉内,比蛛网膜下腔阻滞下静脉输注咪达唑仑75 mcg / kg或静脉注射氯胺酮0.5 mg / kg的效果更佳。合并使用后,低血压,恶心,呕吐和瘙痒的副作用也很少,证明它是预防区域麻醉后发抖的更好药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号